We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
With GlaxoSmithKline CFO Simon Dingemans on his way out, the pharma giant needed someone to push through its newly announced restructuring plan. And CEO Emma Walmsley has made her choice.